Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03730402 · ClinicalTrials.gov registry record · Phase 4
Laparoscopic Assisted Plane Block (LAPB) Trial
A Phase 4 study, sponsored by Santa Barbara Cottage Hospital.
- Terminated
- Registry status
- Phase 4
- Development phase
- 34
- Enrollment target
NCT03730402 is a Phase 4 study that was terminated before completion, run by Santa Barbara Cottage Hospital. The registered enrollment target is 34 participants.
The verdict
NCT03730402, a Phase 4 study, was terminated before completion, sponsored by Santa Barbara Cottage Hospital.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 34 participants
- Enrollment target
Study Summary
This study attempts to demonstrate improvement in analgesia in a more diverse laparoscopic surgery group with the use of laparoscopic assisted transversus abdominis plane blocks. The investigators will compare bupivacaine (treatment arm 1) versus liposomal bupivacaine (treatment arm 2) versus port site injection of local anesthesia with injection of saline placebo (control). The hypothesis is that liposomal bupivacaine will result in improved analgesia when compared to bupivacaine LAPB and control. The investigators further hypothesize that bupivacaine LAPB will be more effective than the control.
Interventions
- DRUG Bupivacaine
- DRUG Saline
- DRUG Exparel 266 milligram Per 20 ML Injection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34 participants |
| Start Date | 2019-02-04 |
| Est. Completion | 2021-04-14 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03730402
The ClinicalTrials.gov registry entry for NCT03730402 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 34 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Santa Barbara Cottage Hospital, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Bupivacaine is the first listed.
NCT03730402 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03730402 about?
NCT03730402 is a clinical study titled "Laparoscopic Assisted Plane Block (LAPB) Trial". This study attempts to demonstrate improvement in analgesia in a more diverse laparoscopic surgery group with the use of laparoscopic assisted transversus abdominis plane blocks. The investigators will compare bupivacaine (treatment arm 1) versus liposomal bupivacaine (treatment arm 2) versus port s...
What is the current status of trial NCT03730402?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 34 participants. The study started on 2019-02-04. Estimated completion is 2021-04-14.
What interventions are being tested in trial NCT03730402?
The interventions under investigation include: Bupivacaine (DRUG), Saline (DRUG), Exparel 266 milligram Per 20 ML Injection (DRUG).
Who is sponsoring clinical trial NCT03730402?
This trial is sponsored by Santa Barbara Cottage Hospital, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.